 <?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
		>

<channel>
	<title>MEDD Australia | Hope For Hearts – Cardiac News and Education | Activity</title>
	<link>https://development.medd.com.au/groups/hope-for-hearts-cardiology/</link>
	<atom:link href="https://development.medd.com.au/groups/hope-for-hearts-cardiology/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for the group, Hope For Hearts – Cardiac News and Education.</description>
	<lastBuildDate>Sat, 25 Apr 2026 12:54:37 +1000</lastBuildDate>
	<generator>https://buddypress.org/?v=2.21.0</generator>
	<language>en-AU</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
		
								<item>
				<guid isPermaLink="false">c207a90dd9d5cf269483e69f70ee9d0f</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: ACC Guidance: Weight Management Medications as [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/15570/</link>
				<pubDate>Thu, 03 Jul 2025 02:50:57 +1000</pubDate>

									<content:encoded><![CDATA[<p><b>ACC Guidance: Weight Management Medications as First-Line for CV Risk Reduction</b></p>
<p>The American College of Cardiology (ACC) has issued new Concise Clinical Guidance, advocating for the earlier and more prominent use of modern obesity medications, such as GLP-1 and GIP agonists, in patients where weight management can significantly&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-15570"><a href="https://development.medd.com.au/news-feed/p/15570/" rel="nofollow"> Read more</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.acc.org/About-ACC/Press-Releases/2025/06/20/14/11/American-College-of-Cardiology-Issues-Guidance-on-Weight-Management-Drugs" target="_blank"><img src="https://development.medd.com.au/wp-content/uploads/2025/07/9E7FA8BE7B44449AB9993CC9237EF455.png" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">acc.org</p><p class="activity-link-preview-title"><a href="https://www.acc.org/About-ACC/Press-Releases/2025/06/20/14/11/American-College-of-Cardiology-Issues-Guidance-on-Weight-Management-Drugs" target="_blank" rel="nofollow">American College of Cardiology Issues Guidance on Weight Management Drugs - American College of Cardiology</a></p><div class="activity-link-preview-excerpt"><p>American College of Cardiology Issues Guidance on Weight Management Drugs - American College of Cardiology</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4ed327c02e077fb8cd2d1d788a2056e8</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: High-Normal Testosterone Levels Linked to Increased [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/15568/</link>
				<pubDate>Thu, 03 Jul 2025 02:40:41 +1000</pubDate>

									<content:encoded><![CDATA[<p><b>High-Normal Testosterone Levels Linked to Increased Atrial Fibrillation Risk in Older Men</b></p>
<p>Further analysis of the Australian-led ASPREE study reveals that healthy older men with higher <b>endogenous total testosterone concentrations</b>, even within the high-normal range, have an increased risk of developing incident atrial fibrillation (AF). This&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-15568"><a href="https://development.medd.com.au/news-feed/p/15568/" rel="nofollow"> Read more</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">thelancet.com</p><p class="activity-link-preview-title"><a href="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00190-1/fulltext" target="_blank" rel="nofollow">Just a moment...</a></p><div class="activity-link-preview-excerpt"><p>Just a moment...</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fd488ddd198abd9757ee93da9ff222e0</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Early Childhood Food Insecurity Linked to [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/15562/</link>
				<pubDate>Wed, 02 Jul 2025 04:09:45 +1000</pubDate>

									<content:encoded><![CDATA[<p><b>Early Childhood Food Insecurity Linked to Poorer Cardiovascular Health in Young Adulthood. </b><span>A cohort study indicates a significant association between <b>food insecurity experienced in early childhood</b> and <b>worse cardiovascular health outcomes in young adulthood</b>. Highlighting the critical role of early life social determinants of health,&hellip;</span></p>
<p><span class="activity-read-more" id="activity-read-more-15562"><a href="https://development.medd.com.au/news-feed/p/15562/" rel="nofollow"> Read more</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamacardiology/article-abstract/2833872" target="_blank" rel="nofollow">Just a moment...</a></p><div class="activity-link-preview-excerpt"><p>Just a moment...</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e8c500a6c1f863a373d4147f60f3cee4</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: A new JAMA study finds that adults diagnosed with type [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/15390/</link>
				<pubDate>Thu, 22 May 2025 02:34:58 +1000</pubDate>

									<content:encoded><![CDATA[<p><span>A new </span><em>JAMA</em><span> study finds that adults diagnosed with type 1 diabetes after age 40 face <b>significantly higher risks of death and cardiovascular disease</b>—often exceeding those diagnosed at younger ages. </span><span><u>Key points:</u></span></p>
<ul>
<li>
<p>Adults diagnosed after age 40 were found to have <strong>2x higher risk of death</strong> vs. type 2 diabetes and <strong>4x higher cardiovascular mortality</strong> vs.&hellip;</p>
</li>
</ul>
<p><span class="activity-read-more" id="activity-read-more-15390"><a href="https://development.medd.com.au/news-feed/p/15390/" rel="nofollow"> Read more</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">academic.oup.com</p><p class="activity-link-preview-title"><a href="https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaf304/8127980" target="_blank" rel="nofollow">Just a moment...</a></p><div class="activity-link-preview-excerpt"><p>Just a moment...</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e5ef4e5bee0be254437e8cc0458080ee</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: New research suggests that intermittent fasting may [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/15283/</link>
				<pubDate>Wed, 30 Apr 2025 04:51:42 +1000</pubDate>

									<content:encoded><![CDATA[<p>New research suggests that intermittent fasting may reduce blood clot risk by boosting the production of indole-3-propionic acid from gut microorganisms, potentially lowering blood clotting factors.</p>
<p>The study involved CAD patients treated with aspirin who were randomly assigned to either the IF or ad libitum (AL) groups. The IF group was advised&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-15283"><a href="https://development.medd.com.au/news-feed/p/15283/" rel="nofollow"> Read more</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">academic.oup.com</p><p class="activity-link-preview-title"><a href="https://academic.oup.com/lifemeta/article/4/2/loaf002/7989360?login=false#507994803" target="_blank" rel="nofollow">Just a moment...</a></p><div class="activity-link-preview-excerpt"><p>Just a moment...</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d088c9e2cd7d3f95f39eb9f3be31f130</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Several antiviral drugs have been repurposed or [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/14127/</link>
				<pubDate>Sun, 13 Oct 2024 23:38:37 +1100</pubDate>

									<content:encoded><![CDATA[<p>Several antiviral drugs have been repurposed or investigated for COVID-19 treatment, with a recent review highlighting their potential cardiovascular adverse effects. <a target='_blank' href="https://www.nature.com/articles/s41401-024-01382-w" rel="nofollow">https://www.nature.com/articles/s41401-024-01382-w</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.nature.com/articles/s41401-024-01382-w" target="_blank"><img src="https://development.medd.com.au/wp-content/uploads/2024/10/41401_2024_1382_Fig1_HTML.png" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">nature.com</p><p class="activity-link-preview-title"><a href="https://www.nature.com/articles/s41401-024-01382-w" target="_blank" rel="nofollow">Cardiovascular adverse effects of antiviral therapies for COVID-19: Evidence and plausible mechanisms - Acta Pharmacologica Sinica</a></p><div class="activity-link-preview-excerpt"><p>Antiviral therapeutics have made a critical contribution in mitigating the symptoms and clinical outcomes of the coronavirus disease of 2019 (COVID-19), in which a single-stranded RNA viral pathogen, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes multi-organ injuries. Several &hellip; <a class="activity-link-preview-more" href="https://www.nature.com/articles/s41401-024-01382-w" target="_blank" rel="nofollow">Continue reading</a></p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b45ca3ed25073a25b2350258c7faa7fc</guid>
				<title>Drew Miller posted an update in the group Hope For Hearts – Cardiac News and Education: Heart transplants from donors after circulatory death [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3684/</link>
				<pubDate>Fri, 28 Jul 2023 01:38:49 +1000</pubDate>

									<content:encoded><![CDATA[<p>Heart transplants from donors after circulatory death were found to have similar survival rates at 6 months compared to transplants from brain-dead donors, indicating the potential efficacy and safety of circulatory-death donor hearts.</p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">nejm.org</p><p class="activity-link-preview-title"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2212438" target="_blank" rel="nofollow">Just a moment...</a></p><div class="activity-link-preview-excerpt"><p>Just a moment...</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0720002fd8d73fc48ad3d490cca1bd06</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Beta-blockers have largely been controversial in [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3644/</link>
				<pubDate>Thu, 20 Jul 2023 05:35:19 +1000</pubDate>

									<content:encoded><![CDATA[<p>Beta-blockers have largely been controversial in some patients with HF, but do they have a role in mildly reduced HF (HFmrEF) or preserved HF patients (HFpEF)?</p>
<p><a target='_blank' href="https://www.sciencedirect.com/science/article/abs/pii/S2213177923001737" rel="nofollow">https://www.sciencedirect.com/science/article/abs/pii/S2213177923001737</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">sciencedirect.com</p><p class="activity-link-preview-title"><a href="https://www.sciencedirect.com/science/article/abs/pii/S2213177923001737" target="_blank" rel="nofollow">ScienceDirect</a></p><div class="activity-link-preview-excerpt"><p>ScienceDirect</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">44f7e451673bcdaf115b938597bc9c7a</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Should we add specific biomarkers in the search for [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3600/</link>
				<pubDate>Fri, 14 Jul 2023 07:14:48 +1000</pubDate>

									<content:encoded><![CDATA[<p>Should we add specific biomarkers in the search for patients with Heart Failure? <a target='_blank' href="https://onlinelibrary.wiley.com/doi/10.1002/ejhf.2887" rel="nofollow">https://onlinelibrary.wiley.com/doi/10.1002/ejhf.2887</a> </p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0171f63d2e6d85d0db15429f6e7a3eea</guid>
				<title>Drew Miller posted an update in the group Hope For Hearts – Cardiac News and Education: Compared to relative risk reduction, how effective [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3582/</link>
				<pubDate>Wed, 12 Jul 2023 02:29:44 +1000</pubDate>

									<content:encoded><![CDATA[<p>Compared to relative risk reduction, how effective are statins in reducing overall patient mortality?</p>
<p>View the recent study: <a target='_blank' href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2790055" rel="nofollow">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2790055</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2790055" target="_blank"><img src="https://cdn.jamanetwork.com/ama/content_public/journal/intemed/938903/ioi220004f1_1650900292.52586.png?Expires=2147483647&#038;Signature=AtgCxIdT9rQZoBUiLB2xMtNwVp5lmmN6H9oqODSsd7G~D--eWOeefMm1-YEkxmy5ofrLX4EFVmerRVNLVDSzAamL6NCv3lldkoB23YNuV0sD-jRO5c6eMJLqBi-HU7UIj8y32c5iODHRThxny0XAyjOFEQopo1UujN8Oi6G-wzijbHj5iuKNpgzcmMs-Mf7yjLV0LIbkcKo79K8Tfbro9ihi2bmIWMopcDhG69RGRzab6Pr0w8h8V~x1KdF-gpGxx2OnhlhdLFW976ZLK~bk8w2BJPG4qRI5C9cQ3uoIypOrnFJfNDTeQwZrtYPOWx8Bniz1-Fklqhh9aqgCcmLk8Q__&#038;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2790055" target="_blank" rel="nofollow">Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment</a></p><div class="activity-link-preview-excerpt"><p>This systematic review and meta-analysis examines the association between absolute reductions in low-density lipoprotein cholesterol levels with treatment with statin therapy and all-cause mortality, myocardial infarction, and stroke.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d912386c468a64a8584e46f43ed1d5dc</guid>
				<title>Drew Miller posted an update in the group Hope For Hearts – Cardiac News and Education: Does Sacubitril/Valsartan improve HF outcomes and reduce [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3528/</link>
				<pubDate>Wed, 21 Jun 2023 01:12:53 +1000</pubDate>

									<content:encoded><![CDATA[<p>Does Sacubitril/Valsartan improve HF outcomes and reduce CV risk compared to just Valsartan alone?</p>
<p>Find out more: <a target='_blank' href="https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2023/05/30/01/09/sacubitril-valsartan-in-heart-failure?utm_medium=social&#038;utm_source=twitter_post&#038;utm_campaign=twitter_post" rel="nofollow">https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2023/05/30/01/09/sacubitril-valsartan-in-heart-failure?utm_medium=social&#038;utm_source=twitter_post&#038;utm_campaign=twitter_post</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">acc.org</p><p class="activity-link-preview-title"><a href="https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2023/05/30/01/09/sacubitril-valsartan-in-heart-failure?utm_medium=social&#038;utm_source=twitter_post&#038;utm_campaign=twitter_post" target="_blank" rel="nofollow">Sacubitril/Valsartan in HFmrEF and HFpEF: PARAGLIDE-HF and PARAGON-HF Analyses - American College of Cardiology</a></p><div class="activity-link-preview-excerpt"><p>Marty Tam, MD, FACC</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d6173e6853b0b893dae9eea964f90b07</guid>
				<title>Drew Miller posted an update in the group Hope For Hearts – Cardiac News and Education: Are specific SGLT2i's safe when used in conjunction [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3518/</link>
				<pubDate>Wed, 14 Jun 2023 23:33:46 +1000</pubDate>

									<content:encoded><![CDATA[<p>Are specific SGLT2i&#8217;s safe when used in conjunction with conventional diuretics in patients with heart failure?</p>
<p>View the study: <a target='_blank' href="https://jamanetwork.com/article.aspx?doi=10.1001/jamacardio.2023.1090" rel="nofollow">https://jamanetwork.com/article.aspx?doi=10.1001/jamacardio.2023.1090</a></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f78c2872280b2d287bd1d9bea9009ba8</guid>
				<title>Drew Miller posted an update in the group Hope For Hearts – Cardiac News and Education: Are low-dose, multi-combination antihypertensive [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3512/</link>
				<pubDate>Tue, 13 Jun 2023 02:01:52 +1000</pubDate>

									<content:encoded><![CDATA[<p>Are low-dose, multi-combination antihypertensive therapies safe, effective, and well-tolerated in the general community?</p>
<p><span>View the study here: <a target='_blank' href="https://jamanetwork.com/journals/jamacardiology/article-abstract/2804313" rel="nofollow">https://jamanetwork.com/journals/jamacardiology/article-abstract/2804313</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://jamanetwork.com/journals/jamacardiology/article-abstract/2804313" target="_blank"><img src="https://development.medd.com.au/wp-content/uploads/2023/06/hbr230003f1_1681999274.30229.png" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamacardiology/article-abstract/2804313" target="_blank" rel="nofollow">Low-Dose Triple and Quadruple Combination Pills vs Monotherapy, Usual Care, or Placebo for Hypertension</a></p><div class="activity-link-preview-excerpt"><p>This systematic review and meta-analysis evaluates the safety and efficacy of low-dose combination therapy vs monotherapy, usual care, and placebo for early treatment of hypertension.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">055211dfbcb2cf9ad0c065ce7b37be00</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Aspirin or Clopidogrel for diabetic patients with [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3463/</link>
				<pubDate>Fri, 26 May 2023 00:50:16 +1000</pubDate>

									<content:encoded><![CDATA[<p>Aspirin or Clopidogrel for diabetic patients with coronary stents, which to choose? </p>
<p><a target='_blank' href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2803932" rel="nofollow">https://jamanetwork.com/journals/jamacardiology/fullarticle/2803932</a> </p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2803932" target="_blank"><img src="https://development.medd.com.au/wp-content/uploads/2023/05/hoi230014f1_1681134691.72181.png" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2803932" target="_blank" rel="nofollow">Aspirin vs Clopidogrel for Long-term Maintenance After Coronary Stenting in Patients With Diabetes</a></p><div class="activity-link-preview-excerpt"><p>This secondary analysis of the HOST-EXAM randomized clinical trial evaluates clopidogrel vs aspirin for long-term maintenance after percutaneous coronary intervention in patients with diabetes.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">323e4273efd57cf5d27416963f3cfa4d</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Stanford-led study finds sphericity as a possible [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3434/</link>
				<pubDate>Fri, 19 May 2023 02:59:58 +1000</pubDate>

									<content:encoded><![CDATA[<p>Stanford-led study finds sphericity as a possible genetic indicator of cardiac problems, despite being more common in healthy hearts than previously thought.</p>
<p>Learn more: <a target='_blank' href="https://med.stanford.edu/news/all-news/2023/03/heart-shape-predict-disease.html" rel="nofollow">https://med.stanford.edu/news/all-news/2023/03/heart-shape-predict-disease.html</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://med.stanford.edu/news/all-news/2023/03/heart-shape-predict-disease.html" target="_blank"><img src="https://development.medd.com.au/wp-content/uploads/2023/05/Hearts-cropped.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">med.stanford.edu</p><p class="activity-link-preview-title"><a href="https://med.stanford.edu/news/all-news/2023/03/heart-shape-predict-disease.html" target="_blank" rel="nofollow">Stanford Medicine-led study finds heart shape can predict cardiac disease</a></p><div class="activity-link-preview-excerpt"><p>While cardiac sphericity was the focus of Stanford Medicine-led research, the possibility of data science expanding the reach of biomedical science was its true core, researchers say.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d9e038ce94f883fb0751c556c23f782f</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: How do drug-eluting coronary stents compare to [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3406/</link>
				<pubDate>Mon, 15 May 2023 08:21:25 +1000</pubDate>

									<content:encoded><![CDATA[<p>How do drug-eluting coronary stents compare to drug-coated balloons in coronary vascular disease? <a target='_blank' href="https://www.jacc.org/doi/10.1016/j.jcin.2023.02.011" rel="nofollow">https://www.jacc.org/doi/10.1016/j.jcin.2023.02.011</a> </p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">86d4979a9c1b7dea8cd87989d2239679</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Renal Denervation is now an accepted tool for the [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3323/</link>
				<pubDate>Thu, 20 Apr 2023 02:43:06 +1000</pubDate>

									<content:encoded><![CDATA[<p>Renal Denervation is now an accepted tool for the treatment of hypertension across the world.</p>
<p>Click here to read the latest guidelines from the European Society of Cardiology &#8211; <a target='_blank' href="https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehad054/7036012" rel="nofollow">https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehad054/7036012</a> </p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">afdbf9c480b0f131fa514b285523da1f</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Could pre-hospital Troponin testing be effective [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3311/</link>
				<pubDate>Mon, 17 Apr 2023 07:12:26 +1000</pubDate>

									<content:encoded><![CDATA[<p>Could pre-hospital Troponin testing be effective in improving chest pain pathways? <a target='_blank' href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2801009" rel="nofollow">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2801009</a> </p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2801009" target="_blank"><img src="https://development.medd.com.au/wp-content/uploads/2023/04/ioi220082f1_1677616713.94137.png" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2801009" target="_blank" rel="nofollow">Chest Pain Management Using Prehospital Point-of-Care Troponin and Paramedic Risk Assessment</a></p><div class="activity-link-preview-excerpt"><p>This economic evaluation uses cost-minimization analysis to estimate the cost savings of paramedic risk stratification of adult acute chest pain and point-of-care troponin testing.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">cf80cbc747f0583c25623b054594d70a</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Can lowering blood pressure reduce the likelihood of [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3305/</link>
				<pubDate>Fri, 14 Apr 2023 04:42:14 +1000</pubDate>

									<content:encoded><![CDATA[<p>Can lowering blood pressure reduce the likelihood of a secondary stroke? </p>
<p><a target='_blank' href="https://jamanetwork.com/journals/jamaneurology/fullarticle/2802775" rel="nofollow">https://jamanetwork.com/journals/jamaneurology/fullarticle/2802775</a> </p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5d0b6246d64069f1deda39bbfcd6a87e</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Are we closer to having an oral PCSK9 inhibitor that is [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3281/</link>
				<pubDate>Mon, 10 Apr 2023 02:02:44 +1000</pubDate>

									<content:encoded><![CDATA[<p>Are we closer to having an oral PCSK9 inhibitor that is safe and effective?</p>
<p><a target='_blank' href="https://www.healio.com/news/cardiology/20230306/oral-pcsk9-inhibitor-lowers-ldl-similar-to-injection-in-shortterm-phase-2-trial" rel="nofollow">https://www.healio.com/news/cardiology/20230306/oral-pcsk9-inhibitor-lowers-ldl-similar-to-injection-in-shortterm-phase-2-trial</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.healio.com/news/cardiology/20230306/oral-pcsk9-inhibitor-lowers-ldl-similar-to-injection-in-shortterm-phase-2-trial" target="_blank"><img src="https://development.medd.com.au/wp-content/uploads/2023/04/cholesterol-test-results_adobe.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">healio.com</p><p class="activity-link-preview-title"><a href="https://www.healio.com/news/cardiology/20230306/oral-pcsk9-inhibitor-lowers-ldl-similar-to-injection-in-shortterm-phase-2-trial" target="_blank" rel="nofollow">Oral PCSK9 inhibitor lowers LDL similar to injection in short-term phase 2 trial</a></p><div class="activity-link-preview-excerpt"><p>NEW ORLEANS — In a phase 2 trial, an oral PCSK9 inhibitor lowered LDL about the same amount observed with injectable PCSK9 inhibitors for 8 weeks, researchers reported at the American College of Cardiology Scientific Session.For the phase 2b, randomized, &hellip; <a class="activity-link-preview-more" href="https://www.healio.com/news/cardiology/20230306/oral-pcsk9-inhibitor-lowers-ldl-similar-to-injection-in-shortterm-phase-2-trial" target="_blank" rel="nofollow">Continue reading</a></p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ce96efa33ff4994db564f9ce809c97b7</guid>
				<title>Drew Miller posted an update in the group Hope For Hearts – Cardiac News and Education: In a HPrEF patient, can Dapagliflozin improve Hb [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3268/</link>
				<pubDate>Wed, 05 Apr 2023 01:06:37 +1000</pubDate>

									<content:encoded><![CDATA[<p>In a HPrEF patient, can Dapagliflozin improve Hb and functional capacity, QOL and NT-proBNP?</p>
<p>Find out here: <a target='_blank' href="https://www.onlinejcf.com/article/S1071-9164(23)00060-X/fulltext" rel="nofollow">https://www.onlinejcf.com/article/S1071-9164(23)00060-X/fulltext</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.onlinejcf.com/article/S1071-9164(23)00060-X/fulltext" target="_blank"><img src="https://development.medd.com.au/wp-content/uploads/2023/04/gr2.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">onlinejcf.com</p><p class="activity-link-preview-title"><a href="https://www.onlinejcf.com/article/S1071-9164(23)00060-X/fulltext" target="_blank" rel="nofollow">Short-term Changes in Hemoglobin and Changes in Functional Status, Quality of Life, and Natriuretic Peptides after initiation of Dapagliflozin in Heart Failure with Reduced Ejection Fraction</a></p><div class="activity-link-preview-excerpt"><p>Prior studies show a significant increase in hemoglobin and hematocrit following sodium-glucose co-transporter 2 inhibitors (SGLT2i) initiation, being useful for identifying those at lower risk of adverse clinical events.1 In the DAPA-VO2 randomized clinical trial, we found that dapagliflozin significantly &hellip; <a class="activity-link-preview-more" href="https://www.onlinejcf.com/article/S1071-9164(23)00060-X/fulltext" target="_blank" rel="nofollow">Continue reading</a></p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">83a01f5b708f3fc1b350b727c7d1ab3e</guid>
				<title>Drew Miller posted an update in the group Hope For Hearts – Cardiac News and Education: Are we ready for wrist-worn tech to aid in confirming [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3262/</link>
				<pubDate>Mon, 03 Apr 2023 23:31:14 +1000</pubDate>

									<content:encoded><![CDATA[<p>Are we ready for wrist-worn tech to aid in confirming acute myocardial infarction?</p>
<p><span>Learn about it here: </span><span><a target='_blank' href="https://www.healio.com/news/cardiology/20230306/wristworn-sensor-shows-early-promise-for-assessing-likelihood-of-suspected-heart-attack" rel="nofollow">https://www.healio.com/news/cardiology/20230306/wristworn-sensor-shows-early-promise-for-assessing-likelihood-of-suspected-heart-attack</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.healio.com/news/cardiology/20230306/wristworn-sensor-shows-early-promise-for-assessing-likelihood-of-suspected-heart-attack" target="_blank"><img src="https://development.medd.com.au/wp-content/uploads/2023/04/alert-on-heart-monitor.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">healio.com</p><p class="activity-link-preview-title"><a href="https://www.healio.com/news/cardiology/20230306/wristworn-sensor-shows-early-promise-for-assessing-likelihood-of-suspected-heart-attack" target="_blank" rel="nofollow">Wrist-worn sensor shows early promise for assessing likelihood of suspected heart attack</a></p><div class="activity-link-preview-excerpt"><p>NEW ORLEANS — In a new study, use of a wrist-worn sensor was clinically feasible for rapid, bloodless prediction of elevated troponin I in patients with suspected MI, researchers reported at the American College of Cardiology Scientific Session.“Assessing high-sensitivity cardiac &hellip; <a class="activity-link-preview-more" href="https://www.healio.com/news/cardiology/20230306/wristworn-sensor-shows-early-promise-for-assessing-likelihood-of-suspected-heart-attack" target="_blank" rel="nofollow">Continue reading</a></p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7a7ba00d1071b30338c1f0c25621a9bb</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: How well do we treat patients requiring Statins and [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3257/</link>
				<pubDate>Mon, 03 Apr 2023 02:18:26 +1000</pubDate>

									<content:encoded><![CDATA[<p>How well do we treat patients requiring Statins and other lipid-lowering drugs in the real world? <a target='_blank' href="https://academic.oup.com/ehjopen/article/2/6/oeac070/6775424" rel="noopener noreferrer" rel="nofollow">https://academic.oup.com/ehjopen/article/2/6/oeac070/6775424</a></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f2e953eacb26882efc40c6d8b2de4161</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Could Rivaroxaban replace Enoxaparin in patients with [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3251/</link>
				<pubDate>Thu, 30 Mar 2023 04:27:06 +1100</pubDate>

									<content:encoded><![CDATA[<p>Could Rivaroxaban replace Enoxaparin in patients with Acute Coronary Syndrome and Dual Antiplatelet Therapy?</p>
<p>Explore the findings: <a target='_blank' href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801235" rel="nofollow">https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801235</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801235" target="_blank" rel="nofollow">Rivaroxaban vs Enoxaparin in Major Cardiac Adverse Events and Bleeding Risk in the Acute Phase of ACS</a></p><div class="activity-link-preview-excerpt"><p>This randomized equivalence and noninferiority trial compares safety and efficacy of enoxaparin vs rivaroxaban 2.5 or 5 mg for patients with acute coronary syndrome (ACS) in the acute phase.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">95dcd108eb7e1367064d43877fdb8927</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: How common is sudden cardiac arrest in older [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3162/</link>
				<pubDate>Fri, 03 Mar 2023 02:30:05 +1100</pubDate>

									<content:encoded><![CDATA[<p>How common is sudden cardiac arrest in older patients? Should we continue to promote exercise in this group?</p>
<p>Read the original investigation: <a target='_blank' href="https://www.jacc.org/doi/abs/10.1016/j.jacep.2022.10.033" rel="nofollow">https://www.jacc.org/doi/abs/10.1016/j.jacep.2022.10.033</a></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">bc99e6d884f19524305c04cf21d24daf</guid>
				<title>Drew Miller posted an update in the group Hope For Hearts – Cardiac News and Education: Do atrial fibrillation (AF) self-screening stations [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3086/</link>
				<pubDate>Fri, 17 Feb 2023 03:55:13 +1100</pubDate>

									<content:encoded><![CDATA[<p>Do atrial fibrillation (AF) self-screening stations in general practice waiting rooms enhance AF screening, diagnosis, and stroke risk management?</p>
<p>Learn more here: <span><a target='_blank' href="https://www.mja.com.au/journal/2023/218/1/increasing-screening-atrial-fibrillation-general-practice-atrial-fibrillation" rel="nofollow">https://www.mja.com.au/journal/2023/218/1/increasing-screening-atrial-fibrillation-general-practice-atrial-fibrillation</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.mja.com.au/journal/2023/218/1/increasing-screening-atrial-fibrillation-general-practice-atrial-fibrillation" target="_blank"><img src="https://development.medd.com.au/wp-content/uploads/2023/02/mja2.51803.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">mja.com.au</p><p class="activity-link-preview-title"><a href="https://www.mja.com.au/journal/2023/218/1/increasing-screening-atrial-fibrillation-general-practice-atrial-fibrillation" target="_blank" rel="nofollow">Increasing screening for atrial fibrillation in general practice: the Atrial Fibrillation Self‐Screening, Management And guideline‐Recommended Therapy (AF Self‐SMART) study</a></p><div class="activity-link-preview-excerpt"><p>AF self-screening in general practice waiting rooms is feasible, and could reduce the number of AF-related strokes</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6f5015dc110f3d26e1a45601d64771c7</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Could there be a link between high LDL levels and [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/3054/</link>
				<pubDate>Thu, 02 Feb 2023 06:38:32 +1100</pubDate>

									<content:encoded><![CDATA[<p>Could there be a link between high LDL levels and fractures? Read the brief report: <a target='_blank' href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2800308" rel="nofollow">https://jamanetwork.com/journals/jamacardiology/fullarticle/2800308</a> </p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2800308" target="_blank"><img src="https://development.medd.com.au/wp-content/uploads/2023/02/hbr220011t1_1672763439.54848.png" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2800308" target="_blank" rel="nofollow">Association of Plasma HDL-C Level With Risk of Fractures in Healthy Older Adults</a></p><div class="activity-link-preview-excerpt"><p>This cohort study performs a post hoc analysis of data for US and Australian participants in the Aspirin in Reducing Events in the Elderly (ASPREE) clinical trial to determine the association between level of high-density lipoprotein cholesterol and increased fracture &hellip; <a class="activity-link-preview-more" href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2800308" target="_blank" rel="nofollow">Continue reading</a></p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4ac5a942f71b60b0ef2622a49526e09e</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Advanced heart disease patients have successfully [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/2970/</link>
				<pubDate>Mon, 26 Dec 2022 00:11:33 +1100</pubDate>

									<content:encoded><![CDATA[<p>Advanced heart disease patients have successfully regained time and quality of life thanks to a novel procedure carried out at Orlando Health using precision radiation therapy.</p>
<p><a target='_blank' href="https://www.eurekalert.org/news-releases/971580" rel="nofollow">https://www.eurekalert.org/news-releases/971580</a> </p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.eurekalert.org/news-releases/971580" target="_blank"><img src="https://earimediaprodweb.azurewebsites.net/Api/v1/Multimedia/fc3537cd-ac58-45b3-80ae-a8c20e1b5b25/Rendition/thumbnail/Content/Public" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">eurekalert.org</p><p class="activity-link-preview-title"><a href="https://www.eurekalert.org/news-releases/971580" target="_blank" rel="nofollow">Experimental treatment uses targeted radiation to treat advanced heart disease</a></p><div class="activity-link-preview-excerpt"><p>Radiation oncologists rarely, if ever, treat the heart. In fact, they try to avoid exposing the heart to x-ray beams at all costs. But a new treatment performed at Orlando Health, using precise radiation therapy, has successfully given time and &hellip; <a class="activity-link-preview-more" href="https://www.eurekalert.org/news-releases/971580" target="_blank" rel="nofollow">Continue reading</a></p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">25130522918697bfdfe4c8384c5ff585</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Is it possible for a single Chest X-Ray to [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/2945/</link>
				<pubDate>Thu, 15 Dec 2022 01:17:17 +1100</pubDate>

									<content:encoded><![CDATA[<p>Is it possible for a single Chest X-Ray to predict cardiovascular disease? Artificial intelligence may help this become a reality. </p>
<p>Read more about this technology: <a target='_blank' href="https://www.medscape.com/viewarticle/984910" rel="nofollow">https://www.medscape.com/viewarticle/984910</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.medscape.com/viewarticle/984910" target="_blank"><img src="https://development.medd.com.au/wp-content/uploads/2022/12/ih_210607_chest_xray_800x450.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">medscape.com</p><p class="activity-link-preview-title"><a href="https://www.medscape.com/viewarticle/984910" target="_blank" rel="nofollow">Single Chest X-Ray Could Predict 10-Year CVD Risk</a></p><div class="activity-link-preview-excerpt"><p>The standard risk calculator requires nine variables, and not all of them are always available in the EHR. The proposed CXR model has performed similarly to the standard model.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2374cdfaae3984b4ff393d9bd208e125</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: According to recent findings from the ABRE research, [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/2885/</link>
				<pubDate>Wed, 30 Nov 2022 03:39:26 +1100</pubDate>

									<content:encoded><![CDATA[<p>According to recent findings from the ABRE research, a self-expanding stent was linked to improvements in patency, quality of life, and functional outcomes in patients with venous outflow obstruction at 36 months.</p>
<p>Click here to read more&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-2885"><a href="https://development.medd.com.au/news-feed/p/2885/" rel="nofollow"> Read more</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.healio.com/news/cardiac-vascular-intervention/20221021/venous-stent-improves-patency-quality-of-life-functional-metrics-at-36-months" target="_blank"><img src="https://development.medd.com.au/wp-content/uploads/2022/11/stent-3d_adobe-stock.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">healio.com</p><p class="activity-link-preview-title"><a href="https://www.healio.com/news/cardiac-vascular-intervention/20221021/venous-stent-improves-patency-quality-of-life-functional-metrics-at-36-months" target="_blank" rel="nofollow">Venous stent improves patency, quality of life, functional metrics at 36 months</a></p><div class="activity-link-preview-excerpt"><p>In patients with venous outflow obstruction, a self-expanding stent was associated with improvements in patency, quality of life and functional outcomes at 36 months, according to new data from the ABRE study. As Healio previously reported, the stent (Abre, Medtronic) &hellip; <a class="activity-link-preview-more" href="https://www.healio.com/news/cardiac-vascular-intervention/20221021/venous-stent-improves-patency-quality-of-life-functional-metrics-at-36-months" target="_blank" rel="nofollow">Continue reading</a></p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1ef0b4e70fa23be1ac904819ee64cf15</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Dizziness and Vertigo can be problematic for patients [&#133;]</title>
				<link>https://development.medd.com.au/news-feed/p/2701/</link>
				<pubDate>Wed, 05 Oct 2022 04:47:02 +1100</pubDate>

									<content:encoded><![CDATA[<p>Dizziness and Vertigo can be problematic for patients and Doctors in General Practice; here are some tips and tricks to help manage these often complex patients.</p>
<p><a target='_blank' href="https://manualofmedicine.com/topics/neurology/approach-to-the-patient-with-vertigo-and-dizziness/" rel="nofollow">https://manualofmedicine.com/topics/neurology/approach-to-the-patient-with-vertigo-and-dizziness/</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://manualofmedicine.com/topics/neurology/approach-to-the-patient-with-vertigo-and-dizziness/" target="_blank"><img src="https://development.medd.com.au/wp-content/uploads/2022/10/Diagnostic-algorithm-for-dizziness-and-vertigo.png" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">manualofmedicine.com</p><p class="activity-link-preview-title"><a href="https://manualofmedicine.com/topics/neurology/approach-to-the-patient-with-vertigo-and-dizziness/" target="_blank" rel="nofollow">Approach to the Patient with Vertigo and Dizziness - Manual of Medicine</a></p><div class="activity-link-preview-excerpt"><p>True vertigo is the false perception (illusion) of movement, usually rotational, of a patient of his or her surroundings. This is often accompanied by vomiting, sweating, and pallor...</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>
		